Microbiologia Medica (Oct 2021)

Humoral immunity after Pfizer/BioNTech BNT162b2 vaccine in healthcare workers of ASL Roma 2 (Italy)

  • Eliana Giberna,
  • Tiziana Guastafierro,
  • Natalia Ciaffi,
  • Elena Nebuloso,
  • Stefania Piccoli,
  • Mattia Serao,
  • Giuseppina Gioffrè,
  • Stefania Campitelli,
  • Maria Grazia Colace,
  • Maria Carmela Cava,
  • Maria De Cristofaro

DOI
https://doi.org/10.4081/mm.2021.9695
Journal volume & issue
Vol. 36, no. 2

Abstract

Read online

The Unit (COU) of Microbiology and Virology of Sandro Pertini Hospital began monitoring the immune response on a cohort of healthcare operators who received the Pfizer/BioNTech BNT162b2 vaccine. Three different tests for the detection of antibodies against SARS-CoV-2 were used showing 100% of seroconversion after 28 days from the first dose.

Keywords